Discovery of microRNA Earns Nobel Prize for Massachusetts Researchers

Posted by ISPE Boston
On November 7, 2024

Gary Ruvkun, professor of genetics at Harvard Medical School and an investigator at Massachusetts General Hospital, and Victor Ambros, of the University of Massachusetts Chan Medical School. have received the 2024 Nobel Prize in Medicine for the discovery of microRNAs, a class of tiny RNA molecules that regulate the activities of genes in plants and animals, including […]

Chapter Member Anniversaries: November 2024

Posted by ISPE Boston
On November 6, 2024

Please congratulate the following members celebrating milestone anniversaries in November 2024. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Michael R. Allard Timothy J. Cotter, Cotter Brothers Corporation Timothy F. Curran, PE, NV5 Christopher P. Foran, Superior Controls Inc Peter T. Fox, E2i, Inc. Michael Gorman Richard […]

Welcome New Members October 2024

Posted by ISPE Boston
On November 6, 2024

We would like to introduce the Members who joined ISPE in October 2024, welcome them to the Chapter, and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]

Simple Approaches to Alarm Management Can Improve Life Sciences Research Continuity

Posted by Tony Tarara
On October 28, 2024

Simple Approaches to Alarm Management Can Improve Life Sciences Research Continuity In life sciences, building managers have big responsibilities. Uptime, research continuity, sample preservation, and regulatory compliance often fall on the shoulders of building managers. Why? Because building managers are the ones that keep labs, cold storage, and first run manufacturing operating. That includes expectations […]

Biotechs Sign Big Lease for Lab Space in Watertown Square

Posted by ISPE Boston
On October 24, 2024

In the largest lease deal for newly-built lab space so far this year, The Davis Companies and Boston Development Group (BDG) have entered into lease agreements with life sciences firms LifeMine Therapeutics and a new stealth-mode biotech (NewCo) for space in the brand-new, purpose-built, 225K square-foot, Class A life science building at 66 Galen Street […]

Seaport Therapeutics Closes $225 Million Financing Round

Posted by ISPE Boston
On October 24, 2024

Neuropsychiatric medicines company Seaport Therapeutics has closed an oversubscribed $225 million Series B financing round. The financing brings the total capital raised by Seaport to $325 million since the company’s launch in April 2024. Seaport will use the proceeds to advance its clinical-stage pipeline of first and best-in-class medicines through important clinical milestones as well […]

Biotech Veteran Launches RNAi Startup

Posted by ISPE Boston
On October 24, 2024

City Therapeutics has launched with $135 million in financing and a vision to lead the future of RNA interference (RNAi)-based medicine. Led by executive chair John Maraganore, founding CEO of Alnylam Pharmaceuticals, the startup aims to harness next-generation engineering of small interfering RNAs (siRNAs) – the “trigger” molecules that mediate RNAi – to build a […]

Upcoming Educational Program on Cell & Gene Therapy

Posted by Jack Campion
On October 23, 2024

Join us on Thursday, November 14th, 2024, for an exciting opportunity to dive into the world of Cell & Gene Therapy at Northeastern University’s Innovation Campus in Burlington, MA. This educational event will highlight the distinct challenges in commercializing autologous therapies and provide a unique learning experience for both newcomers and seasoned professionals. Program Highlights: […]

$21.4M in State Tax Breaks for 19 Biotechs

Posted by ISPE Boston
On October 18, 2024

The Healey-Driscoll administration and the Massachusetts Life Sciences Center (MLSC) have announced $21.4 million in tax incentive awards to 19 life sciences companies. The awards, provided through the MLSC’s Tax Incentive Program, are expected to create 1,155 new life sciences industry jobs in Massachusetts. The MLSC Tax Incentive program is offered to companies engaged in life […]

FDA Approves First-in-Class Schizophrenia Drug from BMS

Posted by ISPE Boston
On October 18, 2024

The FDA has approved Cobenify, an oral medication for the treatment of schizophrenia in adults. Cobenify represents the first new class of schizophrenia medicine in several decades and introduces a fundamentally new approach to treating the illness. “Today’s landmark approval of our first-in-class treatment for schizophrenia marks an important milestone for the community, where after more […]

Page 4 of 116«‹2 345 6 ›»